• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微米和亚微米颗粒扩散边界层宽度的实验测定

Experimental determination of the diffusion boundary layer width of micron and submicron particles.

作者信息

Galli C

机构信息

Pfizer Global Research and Development, 2800 Plymouth Road, Ann Arbor, MI 48105, USA.

出版信息

Int J Pharm. 2006 Apr 26;313(1-2):114-22. doi: 10.1016/j.ijpharm.2006.01.030. Epub 2006 Mar 9.

DOI:10.1016/j.ijpharm.2006.01.030
PMID:16529883
Abstract

Powder dissolution kinetics have shown that for particles in the so called "large" size regime (more than about 50 microm), the dissolution rate scales as the specific surface area, i.e. rate proportional to d(-1) where d is the particle diameter. This is consistent with an effective diffusion boundary layer width h(EFF) that is constant with respect to particle size. However, for particles in the so called "small" size regime (d less than about 50 microm), the dissolution rate has a stronger dependence than proportional to d(-1) [Bisrat, M., Anderberg, E.K., Barnett, M.I., Nystroem, C., 1992. Physicochemical aspects of drug release. XV. Investigation of diffusional transport in dissolution of suspended, sparingly soluble drugs. Int. J. Pharm., 80, 191-201; Mosharraf, M., Nystroem, C., 1995. The effect of particle size and shape on the surface specific dissolution rate of microsized practically insoluble drugs. Int. J. Pharm., 122, 35-47]. In this regime, Prandtl boundary layer theory predicts an h(EFF) approximately equal to the particle radius or diameter. This paper presents the first experimental determination of h(EFF) for particles less than about 2 microm. The powder dissolution kinetics of six suspensions over the particle diameter range of 5.9 +/- 0.1 to 0.53 +/- 0.05 microm are analyzed to yield h(EFF) values of 8.5 +/- 1.9 to 0.34 +/- 0.14 microm. The theoretical expectation for mass transport, dissolution time proportional to d(2.0), is in good agreement with the experimental results of dissolution time proportional to d(2.3). An understanding of these mass transfer mechanisms allows pharmaceutical scientists to achieve targeted release rates with minimum ensemble instability.

摘要

粉末溶解动力学表明,对于处于所谓“大”尺寸范围(大于约50微米)的颗粒,溶解速率与比表面积成比例,即速率与d(-1)成正比,其中d为颗粒直径。这与相对于颗粒尺寸恒定的有效扩散边界层宽度h(EFF)是一致的。然而,对于处于所谓“小”尺寸范围(d小于约50微米)的颗粒,溶解速率的依赖性比与d(-1)成比例更强[比斯拉特,M.,安德伯格,E.K.,巴尼特,M.I.,尼斯特伦,C.,1992年。药物释放的物理化学方面。十五。难溶性悬浮药物溶解中扩散传输的研究。国际药学杂志,80,191 - 201;莫沙拉夫,M.,尼斯特伦,C.,1995年。颗粒大小和形状对微尺寸实际不溶性药物表面比溶解速率的影响。国际药学杂志,122,35 - 47]。在这个范围内,普朗特边界层理论预测h(EFF)大约等于颗粒半径或直径。本文首次对小于约2微米的颗粒进行了h(EFF)的实验测定。分析了六种悬浮液在5.9±0.1至0.53±0.05微米粒径范围内的粉末溶解动力学,得出h(EFF)值为8.5±1.9至0.34±0.14微米。质量传输的理论预期,即溶解时间与d(2.0)成比例,与溶解时间与d(2.3)成比例的实验结果吻合良好。对这些传质机制的理解使药物科学家能够在最小化整体不稳定性的情况下实现靶向释放速率。

相似文献

1
Experimental determination of the diffusion boundary layer width of micron and submicron particles.微米和亚微米颗粒扩散边界层宽度的实验测定
Int J Pharm. 2006 Apr 26;313(1-2):114-22. doi: 10.1016/j.ijpharm.2006.01.030. Epub 2006 Mar 9.
2
Theoretical comparison of hydrodynamic diffusion layer models used for dissolution simulation in drug discovery and development.药物研发中用于溶出模拟的流体动力学扩散层模型的理论比较。
Int J Pharm. 2008 Nov 3;363(1-2):73-7. doi: 10.1016/j.ijpharm.2008.07.002. Epub 2008 Jul 15.
3
Turbidimetric measurement and prediction of dissolution rates of poorly soluble drug nanocrystals.难溶性药物纳米晶体溶出速率的比浊法测定与预测
J Control Release. 2007 Feb 26;117(3):351-9. doi: 10.1016/j.jconrel.2006.11.011. Epub 2006 Nov 17.
4
Miniaturization of powder dissolution measurement and estimation of particle size.粉末溶解测量的微型化和粒度估计。
Chem Biodivers. 2009 Nov;6(11):1796-811. doi: 10.1002/cbdv.200900082.
5
Modeling dissolution of sparingly soluble multisized powders.难溶性多尺寸粉末的溶解建模
J Pharm Sci. 1997 Jun;86(6):726-32. doi: 10.1021/js960417w.
6
Kinetic study of heterogeneous reaction of deliquesced NaCl particles with gaseous HNO3 using particle-on-substrate stagnation flow reactor approach.采用颗粒在基底滞流流动反应器方法对潮解的氯化钠颗粒与气态硝酸的非均相反应进行动力学研究。
J Phys Chem A. 2007 Oct 11;111(40):10026-43. doi: 10.1021/jp072005p. Epub 2007 Sep 13.
7
Dissolution characteristics of cylindrical particles and tablets.圆柱形颗粒和片剂的溶出特性
Int J Pharm. 2006 Mar 9;310(1-2):146-53. doi: 10.1016/j.ijpharm.2005.12.006. Epub 2006 Jan 18.
8
Possible reduction of effective thickness of intestinal unstirred water layer by particle drifting effect.颗粒漂流效应对肠道非搅动水层有效厚度的可能降低作用。
Int J Pharm. 2010 Mar 15;387(1-2):103-9. doi: 10.1016/j.ijpharm.2009.12.014. Epub 2009 Dec 16.
9
Novel ultra-rapid freezing particle engineering process for enhancement of dissolution rates of poorly water-soluble drugs.用于提高难溶性药物溶出速率的新型超快速冷冻颗粒工程工艺。
Eur J Pharm Biopharm. 2007 Jan;65(1):57-67. doi: 10.1016/j.ejpb.2006.07.012. Epub 2006 Jul 26.
10
A new approach in the prediction of the dissolution behavior of suspended particles by means of their particle size distribution.一种通过悬浮颗粒的粒度分布预测其溶解行为的新方法。
J Pharm Biomed Anal. 2005 Oct 4;39(5):900-7. doi: 10.1016/j.jpba.2005.05.014. Epub 2005 Jul 14.

引用本文的文献

1
Stabilized Astaxanthin Nanoparticles Developed Using Flash Nanoprecipitation to Improve Oral Bioavailability and Hepatoprotective Effects.采用快速纳米沉淀法制备的稳定虾青素纳米颗粒,以提高口服生物利用度和肝脏保护作用。
Pharmaceutics. 2023 Oct 31;15(11):2562. doi: 10.3390/pharmaceutics15112562.
2
Influence of Intermolecular Interactions on Crystallite Size in Crystalline Solid Dispersions.分子间相互作用对结晶性固体分散体中微晶尺寸的影响
Pharmaceutics. 2023 Oct 19;15(10):2493. doi: 10.3390/pharmaceutics15102493.
3
Numerical modeling of the dissolution of drug nanocrystals and its application to industrial product development.
药物纳米晶体溶解的数值模拟及其在工业产品开发中的应用。
ADMET DMPK. 2022 Aug 4;10(4):253-287. doi: 10.5599/admet.1437. eCollection 2022.
4
Nano-Dry-Melting: A Novel Technology for Manufacturing of Pharmaceutical Amorphous Solid Dispersions.纳米干熔法:一种制备药物无定形固体分散体的新技术。
Pharmaceutics. 2022 Oct 9;14(10):2145. doi: 10.3390/pharmaceutics14102145.
5
The Study of Cyclosporin A Nanocrystals Uptake and Transport across an Intestinal Epithelial Cell Model.环孢素A纳米晶体在肠道上皮细胞模型中的摄取与转运研究。
Polymers (Basel). 2022 May 12;14(10):1975. doi: 10.3390/polym14101975.
6
Rifampicin-Carbohydrate Spray-Dried Nanocomposite: A Futuristic Multiparticulate Platform For Pulmonary Delivery.利福平-碳水化合物喷雾干燥纳米复合材料:一种用于肺部给药的未来多颗粒平台。
Int J Nanomedicine. 2019 Nov 22;14:9089-9112. doi: 10.2147/IJN.S211182. eCollection 2019.
7
Formulation, optimization, and in vitro-in vivo evaluation of olmesartan medoxomil nanocrystals.奥美沙坦酯纳米晶体的制剂、优化及体内外评价
Drug Deliv Transl Res. 2017 Apr;7(2):292-303. doi: 10.1007/s13346-016-0355-2.
8
Development of a new method to assess nanocrystal dissolution based on light scattering.基于光散射的纳米晶体溶解新方法的开发。
Pharm Res. 2012 Oct;29(10):2887-901. doi: 10.1007/s11095-012-0795-4. Epub 2012 Jun 12.
9
Powder dissolution method for estimating rotating disk intrinsic dissolution rates of low solubility drugs.用于估算低溶解度药物旋转圆盘固有溶出速率的粉末溶出法。
Pharm Res. 2009 Sep;26(9):2093-100. doi: 10.1007/s11095-009-9921-3. Epub 2009 Jun 19.